| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.061 | 0.3 |